{Reference Type}: Editorial
{Title}: Systemic hemodynamics and pediatric lung disease: Mechanistic links and therapeutic relevance.
{Author}: Sehgal A;South AM;Menahem S;
{Journal}: Am J Physiol Heart Circ Physiol
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 5
{Factor}: 5.125
{DOI}: 10.1152/ajpheart.00271.2024
{Abstract}: Chronic lung disease, also known as bronchopulmonary dysplasia affects thousands of infants worldwide each year. The impact on resources is second only to bronchial asthma, with lung function affected well into adolescence. Diagnostic and therapeutic constructs have almost exclusively focussed on pulmonary architecture (alveoli/airways) and pulmonary hypertension. Information on systemic hemodynamics indicates major artery thickness/stiffness, elevated systemic afterload and/or primary left ventricular dysfunction may play a part in a subset of infants with severe neonatal-pediatric lung disease. Understanding the underlying principles with attendant effectors would aid in identifying the pathophysiological course where systemic afterload reduction with angiotensin converting enzyme inhibitors could become the preferred treatment strategy over conventional pulmonary artery vasodilatation.